EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antagonism of 5‐HT7 Receptors as a Promising Target for Gastric Cancer via Apoptotic Pathway

Irfan Cinar, Busra Dincer, Elif Cadirci iD, Salih Kara, Mehmet Ilhan Yildirgan, Zekai Halici, Saziye Sezin Palabiyik-Yucelik iD

Journal of Biochemical and Molecular Toxicology · 2025-06 · 39 (6)

DOI: 10.1002/jbt.70326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 09.06.2025. Verfasst von Irfan Cinar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Kastamonu University, Kastamonu, Türkiye. Hauptthemen laut MEDLINE: Stomach Neoplasms, Receptors, Serotonin, Apoptosis, Sulfonamides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported, in whole or in part, by the Project of The Scientific and Technological Research Council of Türkiye (TUBITAK) (214S006)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although current treatment strategies have improved clinical outcomes for gastric cancer, they present a challenging prognosis that necessitates novel therapeutic approaches. The 5‐HT7 receptor, a member of the serotonin receptor family, plays a significant role in influencing the pathogenesis of various cancer types. This study seeks to investigate the complex interactions among 5‐HT7 receptors, gastric cancer, and apoptotic processes. A comprehensive set of experimental techniques was employed, including in vitro staining assays for apoptosis assessment, real‐time PCR, and cell proliferation assays. The findings indicate that the 5‐HT7 receptor agonist enhances the proliferation of primary gastric tissue cancer cells and KATO‐III cells, whereas treatment with the 5‐HT7 receptor antagonist significantly inhibits cellular proliferation. Analysis of 5‐HT7 receptor mRNA expression in gastric cancer patient populations indicated significantly elevated levels in cancerous tissues when compared to those in healthy tissues. The administration of a 5‐HT7 receptor agonist (LP44) resulted in increased cell proliferation in primary gastric cancer cells and KATO‐III cell lines, whereas treatment with a 5‐HT7 receptor antagonist (SB‐269970) significantly inhibited proliferation. Additionally, KATO‐III cells treated with the 5‐HT7 receptor antagonist demonstrated a marked upregulation of caspase‐3, caspase‐9, and BAX gene mRNA levels. In contrast, treatment with the 5‐HT7 receptor antagonist was associated with a significant reduction in the expression of nuclear factor kappa B and 5‐HT7 receptor mRNA levels. Annexin V‐FITC/PI and Hoechst 33342 staining demonstrated a pronounced apoptotic effect through antagonism of 5‐HT7 receptors compared to other groups. Collectively, the findings of this study suggest that the enhanced expression of 5‐HT7 receptors influences gastric cancer formation by regulating the apoptotic axis. This provides a novel perspective for understanding the molecular mechanisms underlying the potential of 5‐HT7 receptors as a targeted approach for combating gastric cancer via the apoptotic pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsReceptors, SerotoninApoptosisSulfonamidesSerotonin AntagonistsNeoplasm ProteinsHumansCell Line, TumorCell ProliferationPhenolsMaleFemale

Stichwörter der Autor:innen

5‐HT7 receptorsKATO‐III cellsLP44SB‐269970caspase

Substanzen

Receptors, Serotoninserotonin 7 receptorSulfonamidesSB 269970Serotonin AntagonistsPhenolsNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine, Kastamonu University, Kastamonu, Türkiye.
  • Department of Pharmacology, Faculty of Pharmacy, Ondokuz Mayıs University, Samsun, Türkiye.
  • Department of Pharmacology, Faculty of Medicine, Ataturk University, Erzurum, Türkiye.
  • Department of General Surgery, Faculty of Medicine, Ataturk University, Erzurum, Türkiye.
  • Department of Toxicology, Faculty of Pharmacy, Ondokuz Mayıs University, Samsun, Türkiye.

ORCID-Profile: Elif Cadirci, Saziye Sezin Palabiyik-Yucelik

Förderung

  • This study was supported, in whole or in part, by the Project of The Scientific and Technological Research Council of Türkiye (TUBITAK) (214S006).

Zitieren

APA

Cinar, I., Dincer, B., Cadirci, E., Kara, S., Yildirgan, M. I., Halici, Z., & Palabiyik-Yucelik, S. S. (2025). Antagonism of 5‐HT7 Receptors as a Promising Target for Gastric Cancer via Apoptotic Pathway. Journal of Biochemical and Molecular Toxicology, 39(6). https://doi.org/10.1002/jbt.70326

Vancouver

Cinar I, Dincer B, Cadirci E, Kara S, Yildirgan MI, Halici Z, et al. Antagonism of 5‐HT7 Receptors as a Promising Target for Gastric Cancer via Apoptotic Pathway. Journal of Biochemical and Molecular Toxicology. 2025;39(6). doi:10.1002/jbt.70326

BibTeX
@article{Cinar2025,
  author = {Cinar, Irfan and Dincer, Busra and Cadirci, Elif and Kara, Salih and Yildirgan, Mehmet Ilhan and Halici, Zekai and Palabiyik-Yucelik, Saziye Sezin},
  title = {Antagonism of 5‐HT7 Receptors as a Promising Target for Gastric Cancer via Apoptotic Pathway},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  volume = {39},
  number = {6},
  doi = {10.1002/jbt.70326}
}
Kostenlos starten →